2022
DOI: 10.1016/j.jhqr.2021.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Gender differences, inequalities and biases in the management of Acute Coronary Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 71 publications
0
15
0
Order By: Relevance
“…Outcomes after therapeutic interventions may differ between genders [ 215 , 252 , 253 , 254 , 260 , 261 ] ( Table 1 ).…”
Section: Treatment Of Cardiovascular Diseases In Both Sexes: Differen...mentioning
confidence: 99%
See 1 more Smart Citation
“…Outcomes after therapeutic interventions may differ between genders [ 215 , 252 , 253 , 254 , 260 , 261 ] ( Table 1 ).…”
Section: Treatment Of Cardiovascular Diseases In Both Sexes: Differen...mentioning
confidence: 99%
“…A meta-analysis also demonstrated that women have more device-related complications as death, all-cause readmissions, and HF readmissions. At 1-year there MACE and mortality risk after ICD implantation was similar in both sexes [ 261 ]. Moreover, women with HFrEF and a left-bundle branch block undergoing CRT, seem to have more benefit in terms of more pronounced mortality reduction, accompanied by a remarkable reverse remodeling of LV ( Figure 6 ) [ 196 ].…”
Section: Treatment Of Cardiovascular Diseases In Both Sexes: Differen...mentioning
confidence: 99%
“…Till now, CVD is perceived as a condition essentially regarding the male gender, although CV events account for the main cause of mortality and morbidity in postmenopausal women ( 3 ). Obviously, if it is clear that many aspects of CVD are similar in male and female patients, there are significant differences as well ( 4 , 5 ).…”
Section: Biomarkers and Risk Factorsmentioning
confidence: 99%
“…In the setting of acute myocardial infarction (AMI), despite advancements in treatment during the last decades, women continue to have worse short-and long-term outcomes than men [2,3]. Several studies have revealed sex-specific differences in AMI regarding clinical presentation, pathophysiological mechanisms, diagnosis, management, and outcomes [4][5][6][7][8][9][10]. Nevertheless, women remain understudied, as they only represent about 20% of the patients enrolled in AMI clinical trials [7].…”
Section: Introductionmentioning
confidence: 99%